SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001178913-22-004098
Filing Date
2022-11-17
Accepted
2022-11-17 16:56:23
Documents
1
Period of Report
2022-11-16

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 10509
  Complete submission text file 0001178913-22-004098.txt   11967
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Issuer) CIK: 0001534248 (see all company filings)

IRS No.: 813676773 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 15 KAFRISIN ST. TEL AVIV L3 6901658
Business Address
Mor George Adi (Reporting) CIK: 0001851069 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38807 | Film No.: 221399176